Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-24

Clinical Trial Update: Comparison Of Ketorolac Tromethamine Oral Drops Versus Naproxen For Moderate to Severe Back Pain Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ketorolac tromethamine oral drops to naproxen for moderate to severe back pain has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen (Naproxen)
  • ketorolac tromethamine oral drops (ketorolac tromethamine)

Snippet

Sponsor: EMS | Conditions: Back Pain | Phase 3 | Status: COMPLETED